Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Neurology

Long-term Outlook & Stopping Medication

At a Glance

Most people with epilepsy with generalized tonic-clonic seizures alone achieve long-term seizure control on antiseizure medication, but seizure risk may return after withdrawal. A neurologist should assess EEG, seizure-free time, and personal risks before a gradual taper.

The long-term outlook for Epilepsy with generalized tonic-clonic seizures alone (EGTCA) is generally very positive, with many people achieving complete and lasting control of their seizures. However, it is a condition that requires a long-term mindset [1]. Understanding the difference between being “seizure-free on medication” and being “cured” is essential for your long-term safety.

The Success of Treatment

Most people with EGTCA respond exceptionally well to the right medication.

  • Remission Rates: Depending on the specific cohort definition and follow-up length, estimates show that a large majority of patients (roughly 84% to 86% in some cohorts) achieve long-term remission when taking their antiseizure medication (ASM) consistently [2][1].
  • Drug Resistance: A subset of patients (around 16% in some studies) may find their seizures harder to control [1]. Clinically, drug-resistant epilepsy is defined as the failure to achieve seizure control after adequately trying two appropriate and tolerated antiseizure medication regimens. If your seizures persist after two trials, request a referral to a specialized epileptologist to review your diagnosis and explore advanced treatment options.

The Challenge of Stopping Medication

If you have been seizure-free for several years, you and your doctor may eventually discuss medication withdrawal (tapering). While it is tempting to want to be medication-free, EGTCA and other generalized epilepsy syndromes can have a substantial relapse risk when treatment is stopped [1][3].

  • Variable Relapse Risk: Research across different cohorts reports a wide range of relapse rates—from 44% to as high as 88%—depending on the specific study, follow-up length, and exact syndrome [2][1][3].
  • Long-term Susceptibility: The susceptibility to seizures often remains in the brain. In rare case-level evidence, patients have experienced a relapse more than 20 years after they stopped their medication [3].

Evaluating the Risk of Tapering

Deciding to stop medication is a complex choice that must be made individually with your neurologist, balancing the benefits against side effects, cost, and pregnancy plans. There is no universal requirement or guarantee, but certain factors influence success:

  1. Length of Seizure Freedom: Success rates generally improve with longer periods of complete seizure freedom (e.g., 2 to 5 years) before starting a taper [2][4].
  2. The EEG Signal: Your doctor will likely perform a new routine or sleep-deprived EEG. If your brain still shows generalized spike-wave patterns, the risk of a seizure returning if you stop medication is much higher [2][5]. A normal EEG lowers risk in some studies but cannot guarantee that withdrawal will succeed.
  3. Physician Supervision: Never attempt to lower or stop your dose on your own. Patient-initiated tapering is a major predictor of sudden, severe seizure recurrence [2]. A physician-led taper is individualized and done gradually, with the duration varying by drug and patient [5].

Weighing the Consequences of a Relapse

When considering stopping medication, it is important to think about what a “relapse” would mean for your life today using shared decision-making. A single breakthrough seizure during a taper usually means:

  • Loss of Driving Privileges: In most areas, you must stop driving immediately and remain seizure-free for months before being cleared again [4].
  • Injury Risk: A sudden generalized seizure carries risks of falls, burns, or drowning if it happens at an unexpected time [6].
  • Medical Follow-up: If you experience a relapse, contact your clinician urgently. Do not simply restart or double your medication on your own. Restarting or re-titrating medication may require a supervised plan, and seizure control is not guaranteed immediately.

For some patients, continuing daily medication is a preferred choice when weighing the burdens of treatment against the significant life disruptions caused by a breakthrough seizure [2]. Your doctor can help you decide if your personal seizure history and lifestyle make you a good candidate for a trial off medication.

Common questions in this guide

Can EGTCA stay in remission for the long term?
Many people with EGTCA achieve long-term seizure control while taking an appropriate antiseizure medication consistently. Being seizure-free on medication does not necessarily mean the underlying seizure tendency has disappeared, so seizures can return after medication is withdrawn.
How likely is a seizure to return after stopping EGTCA medication?
The risk varies substantially between people and studies, with reported relapse rates ranging from about 44% to 88% in different generalized epilepsy cohorts. Your individual risk depends on factors such as the exact syndrome, seizure-free interval, EEG findings, and how medication is withdrawn.
Does a normal EEG mean I can safely stop my seizure medication?
A normal EEG may be associated with a lower relapse risk in some studies, but it cannot guarantee that seizures will not return. Ongoing generalized spike-wave patterns are associated with higher risk, so your neurologist should combine the EEG result with your seizure history and other factors.
How should antiseizure medication be tapered in EGTCA?
Medication should be reduced gradually according to a schedule created and monitored by your neurologist. The pace depends on the medication and your circumstances, and lowering or stopping the dose on your own can lead to severe seizure recurrence.
What should I do if I have a breakthrough seizure during or after a taper?
Contact your clinician urgently and follow the individualized plan they provide. Do not simply restart the medication or double a dose on your own, because restarting or adjusting treatment may require supervision and seizure control may not return immediately. You may also need to stop driving until you meet local clearance requirements.
When should I see an epileptologist for ongoing seizures?
A specialist epilepsy evaluation is appropriate when seizures continue after two appropriate, tolerated antiseizure medication regimens have been tried. This situation is considered drug-resistant epilepsy, and an epileptologist can reassess the diagnosis and discuss advanced treatment options.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific syndrome and my last EEG, what is my personal statistical risk of relapse if I were to stop my medication?
  2. 2.If I have ongoing seizures despite trying a medication, is it time to refer me to a specialized epileptologist?
  3. 3.If we decide to attempt a medication taper, what would the step-by-step schedule look like, and how long would it take?
  4. 4.If my EEG still shows abnormal patterns, does that mean a medication taper is too risky to try right now?
  5. 5.What exact steps should I take if I have a breakthrough seizure years down the line?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    Epilepsy with generalized tonic-clonic seizures alone: Electroclinical features and prognostic patterns.

    Cerulli Irelli E, Gesche J, Schlabitz S, et al.

    Epilepsia 2024; (65(1)):84-94 doi:10.1111/epi.17809.

    PMID: 37872695
  2. 2

    Prospective study of epilepsy with generalized tonic-clonic seizures alone: Clinical features, response to treatment, and likelihood of medication withdrawal.

    Jaafar F, Wazne J, Hmaimess G, et al.

    Epilepsia open 2024; (9(4)):1426-1436 doi:10.1002/epi4.12981.

    PMID: 38819591
  3. 3

    Oligoepilepsy and lifelong seizure susceptibility in epilepsy with generalized tonic-clonic seizures alone: Experience at an adult tertiary center.

    Peña-Ceballos J, Moloney PB, Kilbride RD, et al.

    Epilepsy research 2024; (202()):107362 doi:10.1016/j.eplepsyres.2024.107362.

    PMID: 38652996
  4. 4

    Discontinuing antiepileptic drugs in long-standing idiopathic generalised epilepsy.

    Vorderwülbecke BJ, Kirschbaum A, Merkle H, et al.

    Journal of neurology 2019; (266(10)):2554-2559 doi:10.1007/s00415-019-09457-z.

    PMID: 31267208
  5. 5

    Seizure freedom and therapy discontinuation in patients with idiopathic generalized epilepsy: retrospective cohort study from a tertiary epilepsy outpatient service.

    Curti DG, Bellini A, Cursi M, et al.

    Journal of neurology 2025; (272(3)):218 doi:10.1007/s00415-025-12890-y.

    PMID: 39985574
  6. 6

    Incidence and predictors of seizure-related injuries among epileptic patients undergoing follow-up treatment at public hospitals in Central Ethiopia.

    Begizew SW, Muluneh BB, Ashine TM, et al.

    Scientific reports 2025; (15(1)):3899 doi:10.1038/s41598-025-86268-5.

    PMID: 39890819

This page is for informational purposes only and does not constitute medical advice. Do not change or stop antiseizure medication without guidance from your neurologist; your personal relapse risk requires individualized care.

Get notified when new evidence is published on Epilepsy with generalized tonic-clonic seizures alone.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.